6 results match your criteria: "Molecular Medical Science Institute[Affiliation]"
Biochim Biophys Acta
March 2008
Molecular Medical Science Institute Otsuka Pharmaceutical Co. Ltd. Kawauchi, Tokushima-shi, Tokushima 771-0192, Japan.
Peptides which mimic functional activities of glycosphingolipids were prepared by a technology of phage-displayed peptide library using monoclonal antibodies against glycosphingolipids. These peptides were named glyco-replica peptides. Peptides prepared with anti-GD1alpha antibody by this technology were found to contain WHW as common motif, and they showed suppressive activity not only on adhesion between hepatic sinusoidal endothelial cells and lymphosarcoma RAW117-H10 cells, but also on metastasis of the tumor cell to the liver and lung.
View Article and Find Full Text PDFStem Cells
April 2007
Molecular Medical Science Institute, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Tokushima, Japan.
Murine megakaryocytes (MKs) are defined by CD41/CD61 expression and acetylcholinesterase (AChE) activity; however, their stages of differentiation in bone marrow (BM) have not been fully elucidated. In murine lineage-negative (Lin(-))/CD45(+) BM cells, we found CD41(+) MKs without AChE activity (AChE(-)) except for CD41(++) MKs with AChE activity (AChE(+)), in which CD61 expression was similar to their CD41 level. Lin(-)/CD41(+)/CD45(+)/AChE(-) MKs could differentiate into AChE(+), with an accompanying increase in CD41/CD61 during in vitro culture.
View Article and Find Full Text PDFNihon Rinsho
November 2004
Molecular Medical Science Institute, Otsuka Pharmaceutical Co. Ltd.
Methods Mol Biol
January 2003
Molecular Medical Science Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima.
Methods Enzymol
March 2001
Molecular Medical Science Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Methods Enzymol
March 2001
Molecular Medical Science Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.